For research use only
| Cat No. | ABC-KH041Y |
| Product Type | Knockout Stable Cell Line |
| Cell Type | Epithelial |
| Species | Human |
| Host Cell | A-431 |
| Source Organ | Skin |
| Disease | Epidermoid Cancer |
| Storage | Liquid Nitrogen |
Human NEK9 Knockout A-431 Cell Line by AcceGen enables study of mitotic regulation, chromosome instability and cancer cell proliferation mechanisms.
Human NEK9 Knockout A-431 Cell Line is generated from human epidermoid carcinoma A-431 cells through CRISPR/Cas9-mediated disruption of the NIMA-Related Kinase 9 (NEK9) gene, a serine/threonine kinase regulating mitotic spindle formation, chromosome segregation, and cell cycle progression. This knockout model exhibits severe mitotic defects including multipolar spindles and chromosome misalignment while maintaining A-431 cells’ characteristic epithelial morphology. The cell line provides a powerful tool for studying centrosome amplification, genomic instability, and cancer aneuploidy, with particular relevance to squamous cell carcinoma research involving PLK1-dependent mitotic regulation. Maintained at low passage numbers (<P20) with genetic stability, the knockout efficiency is validated through genomic PCR, Sanger sequencing, and functional phospho-proteomic analysis demonstrating loss of NEK9-mediated RCC2 phosphorylation. Rigorous quality control confirms the cell line is free of contamination from HIV-1, HBV, HCV, Syphilis, mycoplasma, fungi, yeast, and bacteria.
| Species | Human |
| Cat.No | ABC-KH041Y |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Skin |
| Disease | Epidermoid Cancer |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Knockout Stable Cell Line |
| Host Cell | A-431 |
| Gene Info | NEK9 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The Human NEK9 Knockout A-431 Cell Line is a valuable model for studying mitotic regulation and chromosomal stability in epithelial cancers. This engineered system enables investigation of the NIMA-related kinase’s role in spindle assembly and cell cycle progression. Researchers utilize this knockout line to examine disrupted microtubule dynamics and aberrant mitotic checkpoint signaling in squamous cell carcinoma. The cell line provides a controlled platform for evaluating NEK9-targeted therapies and identifying synthetic lethal interactions in cancer treatment.